Pathophysiology and treatment of trigeminal autonomic cephalalgias;Neues zur pathophysiologie und therapie der trigeminoautonomen kopfschmerzsyndrome

Schmerz

Volumn 22, Issue SUPPL. 1, 2008, Pages 7-10

  Goadsby, P J ^a,b   Cohen, A S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cluster headache; Cranial autonomic efferentia; Paroxysmal hemicrania; SUNCT syndrome; Trigeminal nociceptive afferentia

Indexed keywords

CORTICOSTEROID; GABAPENTIN; INDOMETACIN; LAMOTRIGINE; LIDOCAINE; LITHIUM; METHYSERGIDE; SUMATRIPTAN; TOPIRAMATE; VERAPAMIL;

CLUSTER HEADACHE; FACIAL NERVE; HUMAN; PAROXYSMAL HEMICRANIA; PATHOPHYSIOLOGY; PRIMARY HEADACHE; REFLEX; REVIEW; SUNCT SYNDROME; SYMPTOM; TREATMENT RESPONSE; TRIGEMINAL AUTONOMIC CEPHALALGIA;

ADMINISTRATION, ORAL; AMINES; ANALGESICS; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLUSTER HEADACHE; CYCLOHEXANECARBOXYLIC ACIDS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INDOMETHACIN; LIDOCAINE; MALE; METHYSERGIDE; NOCICEPTORS; OXYGEN INHALATION THERAPY; PAROXYSMAL HEMICRANIA; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN; SUNCT SYNDROME; TRIAZINES; TRIGEMINAL AUTONOMIC CEPHALALGIAS; TRIGEMINAL NERVE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VERAPAMIL;

EID: 40149110782     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-008-0626-z     Document Type: Review

References (0)